AdvisorShares Psychedelics ETF (PSIL) is a AdvisorShares ETF with a 1.00% expense ratio, 32 holdings and $47MM in net assets. Largest sector: Healthcare (100%).
Fee
1.00%
expense ratio
Net assets
$47MM
Launched
Sep 15, 2021
Holdings
32
as of Oct 23, 2026
Top 10 weight
66.1%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
—
Benchmark
—
PSIL's holdings are as of Oct 23, 2026.
Healthcare
100.0%
1
DFTX
DEFINIUM THERAPEUTICS
12.02%
2
CMPS
COMPASS PATHWAYS
11.25%
3
HELP
CYBIN
8.23%
4
LLY
ELI LILLY
5.60%
5
ABBV
ABBVIE
5.43%
6
NBIX
Neurocrine Biosciences
5.11%
7
JNJ
JOHNSON + JOHNSON
4.76%
8
SPTX
Seaport Therapeutics
4.64%
9
RLMD
Relmada Therapeutics
4.57%
10
DRUG
BRIGHT MINDS BIOSCIENCES
4.50%
11
STIM
Neuronetics
4.07%
12
ANRO
Alto Neuroscience
3.74%
13
GHRS
GH Research
3.73%
14
NRXP
NRX Therapeutics
3.36%
15
SUPN
Supernus Pharmaceuticals
3.34%
16
X9USDBLYT
BLACKROCK TREASURY TRUST INSTL 62
2.97%
17
PBM
PSYENCE BIOMEDICAL LTD
2.32%
18
NEUP
Neuphoria Therapeutics
2.24%
19
OPTH
OPTIMI HEALTH
1.91%
20
QNTM
QUANTUM BIOPHARMA-B SUB VOT
1.87%
21
INDV
Indivior Pharmaceuticals
1.16%
22
KTTA
Pasithea Therapeutics
0.95%
23
IXHL
INCANNEX HEALTHCARE
0.93%
24
IGC
India Globalization Capital
0.48%
25
NUMIF
NUMINUS WELLNESS
0.44%
1–25 of 32
Funds listed by how much of their largest holdings they share with PSIL — not a ranking.
Data from AdvisorShares; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.